David Taylor <br/><br/>
The Maudsley Prescribing Guidelines  

 - 	10th edition, revised  
 - Boca Raton  CRC Press  2009 
 - 544 pages 
<br/><br/>Contents:<br/><br/>Chapter 1 Plasma level monitoring of psychotropics and anticonvulsants<br/><br/>Chapter 2 Schizophrenia<br/><br/>Chapter 3 Bipolar disorder<br/><br/>Chapter 4 Depression and anxiety<br/><br/>Chapter 5 Children and adolescents<br/><br/>Chapter 6 Substance misuse<br/><br/>Chapter 7 Use of psychotropics in special patient groups<br/><br/>Chapter 8 Miscellaneous conditions and substances<br/><br/>Index<br/> 
<br/><br/> One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition of Maudsley Prescribing Guidelines returns with fully updated content and new sections on the latest topics of interest in the field of psychiatry. A must-have reference for prescribers, nursing staff, pharmacists, family physicians, and other professions  
<br/><br/><label>ISBN: </label>020309283X 9780203092835  
 = acute adverse effects alcohol Amisulpride antidepressants antipsychotic drugs Arch Gen Psychiatry aripiprazole associated atypical antipsychotics behaviour benzodiazepines Biol Psychiatry bipolar depression bipolar disorder buprenorphine bupropion carbamazepine cardiac Child Adolesc children and adolescents citalopram Clin Psychiatry clinical clozapine clozapine-induced Cochrane Database Syst cognitive controlled trial Database Syst Rev dementia diabetes discontinuation disease donepezil dose double-blind efficacy excreted fluoxetine haloperidol hepatic increased interactions lamotrigine lithium major depressive mania medication meta-analysis metabolism methadone methylphenidate mg/day mirtazapine monitoring neuroleptic Neuropsychopharmacol olanzapine open-label opioid oral overdose paroxetine patients with schizophrenia pharmacokinetics placebo placebo-controlled study placebo-controlled trial plasma levels pregnancy prescribed Psychiatry Psychiatry 1999 Psychiatry 2006 Psychopharmacol 2008 psychosis psychotic psychotropic quetiapine randomised randomized recommended reduced relapse renal impairment reported risk risperidone Schizophr schizophrenia seizures serotonin reuptake inhibitors sertraline serum side effects SSRIs switching symptoms syndrome tardive dyskinesia therapy tolerated toxicity treated treatment treatment-resistant valproate venlafaxine weeks weight gain ziprasidone 
<br/><br/><label>Subjects--Personal Names: </label>-- Medical / Psychiatry / General--Medical / General--	Medical › Psychiatry › General  
<br/><br/><label>Dewey Class. No.: </label>616.8918 TAY